Präoperative kardiovaskuläre Risikoeinschätzung - Therapie

 

 Permissions and Reprints

Die Indikationen für perioperative diagnostische, medikamentöse, interventionelle und operative Maßnahmen sind im Allgemeinen identisch mit denen ohne eine nachfolgende Operation. Die zeitliche Abfolge ist jedoch oft abhängig von zusätzlichen Faktoren wie beispielsweise der Dringlichkeit des operativen Eingriffs und erfordert eine gute Kommunikation und Zusammenarbeit zwischen Chirurgen, Anästhesisten und Internisten.

Literatur

• 1 Foster E D, Davis K B, Carpenter J A, Abele S, Fray D. Risk of noncardiac operation in patients with defined coronary disease: The Coronary Artery Surgery Study (CASS) registry experience.  Ann Thorac Surg. 1986;  41 42-50
  Google Scholar
• 2 Eagle K A, Rihal C S, Mickel M C, Holmes D R, Foster E D, Gersh B J. Cardiac risk of noncardiac surgery. influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program: Coronary Artery Surgery Study.  Circulation. 1997;  96 1882-1887
  Google Scholar
• 3 ACC/AHA Guidelines for perioperative cardiovascular evaluation for noncardiac surgery . Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery.  Circulation. 1996;  93 1278-1317
  Google Scholar
• 4 ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery . Executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).  Circulation. 2002;  105 1257-1267
  Google Scholar
• 5 Moses J W, Leon M B, Popma J J. et al . Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.  N Engl J Med. 2003;  349 1315-1323
  Google Scholar
• 6 Mangano D T, Layug E L, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.  N Engl J Med. 1996;  335 1713-1720
  Google Scholar
• 7 Poldermans D, Boersma E, Bax J J. et al . The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.  N Engl J Med. 1999;  341 1789-1794
  Google Scholar
• 8 Boersma E, Poldermans D, Bax J J. et al . Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy.  JAMA. 2001;  285 1865-1873
  Google Scholar
• 9 Poldermans D, Bax J J, Kertai M D. et al . Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery.  Circulation. 2003;  107 1848-1851
  Google Scholar
• 10 Böhm M. Perioperatives Risiko und präoperative Vorbereitung des herzinsuffizienten Patienten zur nichtkardialen Operation.  Internist. 2000;  41 283-291
  Google Scholar
• 11 Packer M, Bristow M R, Cohn J N. et al . The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group.  N Engl J Med. 1996;  334 1349-1355
  Google Scholar
• 12 The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) . A randomised trial.  Lancet. 1999;  353 9-13
  Google Scholar
• 13 Effect of metoprolol CR/XL in chronic heart failure . Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).  Lancet. 1999;  353 2001-2007
  Google Scholar
• 14 Packer M, Coats A J, Fowler M B. et al . Effect of carvedilol on survival in severe chronic heart failure.  N Engl J Med. 2001;  344 1651-1658
  Google Scholar
• 15 Böhm M, Maack C, Wehrlen-Grandjean M, Erdmann E. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).  Z Kardiol. 2003;  92 668-676
  Google Scholar
• 16 The Digitalis Investigation Group . The effect of digoxin on mortality and morbidity in patients with heart failure.  N Engl J Med. 1997;  336 525-533
  Google Scholar
• 17 Tauke J, Goldstein S, Gheorghiade M. Digoxin for chronic heart failure: a reviwe of the randomized controlled trials with special attention to the PROVED and RADIANCE Trials.  Prog Cardiovasc Res. 1994;  37 49-58
  Google Scholar
• 18 Jung J, Böhm M. Vorhofflimmern - Therapie.  Dtsch Med Wochenschr. 2001;  126 1472-1475
  Google Scholar
• 19 Cremers B, Böhm M. Kalziumantagonisten in der Therapie der Herzinsuffizienz. Stuttgart, New York: Schattauer In: Kalziumantagonisten-Handbuch. Bönner G, Dominiak P, eds 2002: 467-507
  Google Scholar
• 20 Kalman J M, Munawar M, Howes G L. et al . Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation.  Ann Thorac Surg. 1995;  60 1709-1715
  Google Scholar
• 21 Lee T H, Marcantonio E R, Mangione C M. et al . Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.  Circulation. 1999;  100 1043-1049
  Google Scholar
• 22 Fleisher L A, Eagle K A. Clinical practice. Lowering cardiac risk in noncardiac surgery.  N Engl J Med. 2001;  345 1677-1682
  Google Scholar

Dr. med. Bodo Cremers

Klinik für Innere Medizin III, (Kardiologie, Angiologie und Internistische Intensivmedizin), Universitätsklinikum des Saarlandes

66421 Homburg/Saar

Phone: 06841/1623372

Fax: 06841/1623369

Email: cremers@med-in.uni-sb.de